Decoding GLP-1s: How Weight Loss Drugs Are Reshaping Markets

DALLAS, TX — September 21, 2026 — GLP-1 medications are reshaping consumer behavior, significantly reducing food consumption occasions and forcing major shifts across industries. Guest Rachel Buss highlights how restaurants and CPG brands are pivoting to smaller portions and protein-heavy messaging to avoid alienating discreet consumers.

She emphasizes that businesses must look beyond superficial data, address human nuances, and adapt strategy to broad economic disruptions, from casual dining and grocery retail to fitness, apparel, and home services.